Minor Erythroid Response and Decreased WT1 Expression After Proteasome Inhibition by Bortezomib in Myelodysplastic Syndromes (GIMEMA MDS0104 Phase II Trial) / Breccia, M; Latagliata, R; Cannella, L; Carmosino, I; Gottardi, E; Cilloni, D; Vignetti, M; Santopietro, M; Mancini, M; Alimena, G. - In: BLOOD. - ISSN 0006-4971. - 114:(2009). ( ASH).
Minor Erythroid Response and Decreased WT1 Expression After Proteasome Inhibition by Bortezomib in Myelodysplastic Syndromes (GIMEMA MDS0104 Phase II Trial)
Breccia M;
2009
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
